SonoFusion
A New Ultrasound Non-Invasive Surgery Platform
Health Tech & Life Sciences
Private
Company Overview
Snapshot
Founded in May 2023, SonoFusion operates with 1–10 employees. The company is currently in the R&D product stage, focusing on developing its innovative ultrasound treatment platform.
Business overview
SonoFusion is a Health Tech & Life Sciences company developing an innovative ultrasound treatment platform. Its core technology combines histotripsy and thermal ablation to deliver precise, non-invasive ultrasound procedures. The company serves the medical devices industry within the broader healthcare and life sciences markets, operating in sectors such as medical devices and diagnostics devices across geomarkets including Middle Africa, Europe, North America, and Asia.
Log in to access full profile ›Company Intelligence Q&A
- What is SonoFusion's primary focus?
- SonoFusion is focused on developing an innovative ultrasound treatment platform that combines histotripsy and thermal ablation for precise, non-invasive ultrasound procedures.
- When was SonoFusion founded?
- SonoFusion was founded in May 2023.
- What is the current product stage of SonoFusion?
- SonoFusion's product, an innovative ultrasound treatment platform, is currently in the Research and Development (R&D) stage, focusing on advancing its core technology.
- What markets does SonoFusion target?
- SonoFusion targets geomarkets including Middle Africa, Europe, North America, and Asia, focusing on the medical devices industry.
- What is SonoFusion's business model?
- SonoFusion operates on a B2B business model.